Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
June 11, 2019 Off

Global Obesity Clinical Trial Pipeline Highlights Report 2019 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Obesity Clinical Trial Pipeline Highlights – 2019” report has been added to ResearchAndMarkets.com’s offering. Obesity Pipeline Highlights…

June 11, 2019 Off

Osteoarthritis Clinical Trial Pipeline Highlights Report 2019 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Osteoarthritis Clinical Trial Pipeline Highlights – 2019” report has been added to ResearchAndMarkets.com’s offering. This report, Osteoarthritis…

June 11, 2019 Off

Endometriosis Clinical Trial Pipeline Highlights 2019 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Endometriosis Clinical Trial Pipeline Highlights – 2019” report has been added to ResearchAndMarkets.com’s offering. Endometriosis Pipeline Highlights…

June 11, 2019 Off

2019 Brain Metastases Clinical Trial Pipeline Report – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Brain Metastases Clinical Trial Pipeline Highlights – 2019” report has been added to ResearchAndMarkets.com’s offering. Brain Metastases…

June 11, 2019 Off

2019 Insomnia Clinical Trial Pipeline Highlights – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Insomnia Clinical Trial Pipeline Highlights – 2019” report has been added to ResearchAndMarkets.com’s offering. This report, Insomnia…

June 11, 2019 Off

Genentech’s Gazyva (Obinutuzumab) Delivers Positive Topline Results for Phase II Lupus Nephritis Study

By BusinessWire

NOBILITY showed that Gazyva helped more patients achieve a complete renal response when added to standard of care The Phase…

June 11, 2019 Off

Genentech’s Gazyva (Obinutuzumab) Delivers Positive Topline Results for Phase II Lupus Nephritis Study

By BusinessWire

NOBILITY showed that Gazyva helped more patients achieve a complete renal response when added to standard of care The Phase…

June 11, 2019 Off

Full data from CAROLINA® outcome trial support long-term cardiovascular safety profile of Trajenta®

By BusinessWire

CAROLINA® demonstrated no increased cardiovascular risk for Trajenta® (linagliptin) versus glimepiride in the only active-comparator cardiovascular outcome trial for a…

June 10, 2019 Off

Global Paroxysmal Nocturnal Hemoglobinuria Clinical Trial Pipeline Highlights, 2019 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Paroxysmal Nocturnal Hemoglobinuria Clinical Trial Pipeline Highlights, 2019” report has been added to ResearchAndMarkets.com’s offering. This report…

June 10, 2019 Off

Urinary Tract Infections – Global Clinical Trial Pipeline Highlights, 2019 – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Global Urinary Tract Infections Clinical Trial Pipeline Highlights – 2019” report has been added to ResearchAndMarkets.com’s offering. This…

Posts pagination

Previous 1 … 3,108 3,109 3,110 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine